Derma-Smoothe/FS® Scalp Oil is a low to medium potency corticosteroid indicated for adult patients with psoriasis of the scalp. It is designed for topical use on the scalp, typically applied as an overnight treatment or for at least 4 hours with the scalp covered by a shower cap to enhance effectiveness.
Indications and Usage
In adult patients for psoriasis of the scalp. For the treatment of scalp psoriasis, wet or dampen hair and scalp thoroughly. Apply a thin film of Derma-Smoothe/FS® on the scalp, massage well and cover scalp with the supplied shower cap. Leave on overnight or for a minimum of 4 hours before washing off. Wash hair with regular shampoo and rinse thoroughly.
Dosage and Administration
Derma-Smoothe/FS Scalp Oil is applied to the scalp in adults with scalp psoriasis by wetting the hair and scalp, applying a thin film of the oil, massaging it in, and covering with the shower cap overnight or for at least 4 hours, then washing the hair as usual. Dosing specifics emphasize treatment of scalp psoriasis with overnight application and subsequent cleansing.
Important Safety Information
Contraindications: Patients with hypersensitivity to Derma-Smoothe/FS Scalp Oil or its ingredients.
Warnings & Precautions: Topical corticosteroids can produce reversible HPA axis suppression, Cushing’s syndrome, hyperglycemia, and glucosuria. Because of potential systemic absorption, use of topical corticosteroids may require evaluation for HPA axis suppression. Potent corticosteroids, use on large areas, prolonged use, or occlusive use may increase systemic absorption. If HPA axis suppression develops, modify treatment. Local adverse reactions may occur with topical corticosteroids, including atrophy, striae, acneiform eruptions, hypopigmentation, and allergic contact dermatitis, and may be more likely with occlusive use or more potent corticosteroids. Children may be more susceptible to systemic toxicity from equivalent doses. The most common adverse reactions (>5%) were telangiectasia (9%), erythema (5%), itching (5%), irritation (5%), and burning (5%). Derma-Smoothe/FS is for topical use only; not for oral, ophthalmic, or vaginal use. This safety information is not comprehensive.
Additional context within the draft mentions related corticosteroids and observational data, including discussions of peanut oil in other formulations. While these details provide background on corticosteroid mechanisms and percutaneous absorption, the key safety takeaways focus on potential HPA axis suppression, local skin reactions, and careful use in children and on large areas or under occlusion.
Mechanism and Pharmacology (Summary)
Corticosteroids exert anti-inflammatory, antipruritic, and vasoconstrictive properties. The exact anti-inflammatory mechanism involves modulation of mediators of inflammation, though the precise pathways in topical steroids remain complex. The extent of percutaneous absorption depends on vehicle, epidermal integrity, occlusion, and disease state. Occlusion can enhance penetration, and systemic absorption may occur even with topical use, warranting monitoring for HPA axis suppression in long-term or extensive applications.
Instructions for Use
- For scalp psoriasis, wet hair and scalp thoroughly. Apply a thin film of the scalp oil to the scalp, massage well, and cover with the supplied shower cap.
- Leave on overnight or for at least 4 hours before washing off; wash hair with regular shampoo and rinse thoroughly.
- Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
- Do not use on sensitive areas such as the face unless directed by a physician.
Special Considerations for Children
Children may be more susceptible to systemic toxicity from equivalent doses due to larger skin surface area to body mass ratios. Use caution and periodic evaluation for signs of HPA axis suppression or glucocorticoid adverse effects. Report any signs of systemic effects or unusual skin reactions to a healthcare professional promptly.
Adverse Effects (Overview)
Common local adverse reactions may include burning, itching, irritation, and redness. More rarely, systemic corticosteroid exposure can lead to HPA axis suppression and related effects, particularly with prolonged use, large treated areas, or occlusive dressings. The article notes a range of possible local reactions and emphasizes that adverse event rates in clinical trials may vary and are not directly comparable across products.
Related Formulations and Labels
Fluocinolone acetonide topical oil 0.01% is another corticosteroid oil for scalp conditions, with similar administration methods (wet/damp hair, apply thin film, occlude with shower cap). It is formulated with refined peanut oil and carries its own risk considerations, including peanut-related allergies and various safety warnings. The comparison underscores that different products in this class have distinct ingredients and labeling requirements, but share common themes around HPA axis suppression risk and local skin reactions.
As with any topical corticosteroid therapy, ensure treatment is tailored by a clinician, especially in cases involving large surface areas, long-term use, or pediatric patients. Continuous monitoring and adherence to prescribed duration are essential to minimize systemic absorption risks and adverse effects.
Practical Notes and Tables (Optional)
| Aspect | Key Point |
|---|---|
| Indication | Adult scalp psoriasis |
| Application | Thin film on scalp, overnight or ≥4 hours, wash out |
| Safety concern | Potential HPA axis suppression with systemic absorption |
| Common local AEs | Burning, itching, irritation, redness |
| Pediatric caution | Higher risk due to skin surface area/body mass |
Infographic suggestion: a labeled diagram showing steps of application, occlusion with shower cap, and duration of overnight therapy to improve reader comprehension.
How to use topical steroids
Video suggestion: a brief demonstration of applying scalp oil with occlusion and washing out after the recommended duration.
Note: The product names and specific formulations mentioned are drawn from the provided material. Ensure any usage aligns with official prescribing information and local labeling.Дополнительные замечания
Как и любые кортикостероидные препараты, дерматологическая практика требует учета индивидуальных факторов: сопутствующих кожных инфекций, степени воспаления, возраста пациента и возможности Occlusion для усиления проникновения. При необходимости смены препарата на менее или более сильный стероид, оценку следует проводить периодически. Список сопутствующих лекарств и условий здоровья следует обсуждать с лечащим врачом.
tags: #corticosteroid #oil #for #scalp